Ignite Creation Date:
2024-05-06 @ 4:36 PM
Last Modification Date:
2024-10-26 @ 2:13 PM
Study NCT ID:
NCT05034107
Status:
COMPLETED
Last Update Posted:
2022-11-03
First Post:
2021-08-22
Brief Title:
Effects of Diffused Ylang-Ylang Essential Oil Amongst Older Persons With Dementia
Sponsor:
Universiti Teknologi Mara
Organization:
Universiti Teknologi Mara
Study Overview
Official Title:
Effects of Diffused Ylang-Ylang Cananga Odorata Essential Oil Amongst Older Persons With Dementia A Pre-Post Quasi-Experimental Study Protocol
Status:
COMPLETED
Status Verified Date:
2022-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Ylang-Ylang Cananga Odorata essential oil has been postulated to have calming effect which may improve BPSD in persons with dementia This study aims to examine dementia-related behavioural changes using established assessment tools and brain derived neurotropic factor BDNF in persons with BPSD
Detailed Description:
Behavioural and Psychological Symptoms of Dementia BPSD refers to the spectrum of non-cognitive and non-neurological symptoms of dementia such as agitation psychosis depression and apathy Ylang-Ylang Cananga Odorata essential oil is postulated to have calming effect which may improve BPSD in persons with dementia Thus this study aims to examine dementia-related behavioural changes using established assessment tools and brain derived neurotropic factor BDNF in persons with BPSD A pre-post quasi-experimental pilot study will be conducted over a two-month period in nursing homes with persons with dementia Approximately 30 persons with dementia are expected to participate in this study During the pre-intervention phase water will be diffused using a diffuser in a common area of the nursing homes During the intervention phase Ylang-Ylang essential oil will be diffused using the identical diffuser over the same common area Both water and essential oil will be diffused twice a day each for a duration of 20 min during the respective phases Observation and documentation of behavioural symptoms will be taken using validated instruments during the pre- and post-intervention phases In addition 10 mL of blood will also be collected at pre and post intervention for biochemical analysesIf Ylang-ylang essential oil were found to be beneficial based on the laboratory and observational findings it can be possibly used as an alternative approach in managing BPSD
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None